Key result
Higher D-dimer levels during the acute period of ischemic stroke in anticoagulation-naïve patients with non-valvular atrial fibrillation were independently associated with severe neurologic deficits.
Why the study?
Do D-dimer and troponin I levels correlate with stroke severity in anticoagulation-naïve patients with acute ischemic stroke due to non-valvular atrial fibrillation?
Observational (n=98)
No
Do D-dimer and troponin I levels correlate with stroke severity in anticoagulation-naïve patients with acute ischemic stroke due to non-valvular atrial fibrillation?
Elevated D-dimer levels during the acute phase of NVAF-related ischemic stroke independently correlate with greater stroke severity, suggesting its utility as a marker of thrombus burden.
Answers are grounded in this paper and cite their sources.
May support D-dimer as thrombus burden marker in acute NVAF stroke; hypothesis-generating, should not yet change practice.
Background: A subanalysis study of the ENGAGE AF-TIMI 48 trial showed that cardiac troponin I, N-terminal proB-type natriuretic peptide, and D-dimer, were powerful predictors of cerebrovascular adverse events. We aimed to evaluate D-dimer and cardiac troponin I levels during the acute period of ischemic stroke in anticoagulation-nave patients with nonvalvular atrial fibrillation (NVAF) and also studied the association between these biomarkers and stroke severity.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2018) conducted an observational in Acute ischemic stroke due to non-valvular atrial fibrillation (n=98). Elevated D-dimer levels vs. Lowest quartile of D-dimer levels was evaluated on Moderate-to-severe neurologic deficit (NIHSS ≥10) (OR 29.7, 95% CI 2.0-430.8, p=0.013). Higher D-dimer levels during the acute period of ischemic stroke in anticoagulation-naïve patients with non-valvular atrial fibrillation were independently associated with severe neurologic deficits.
Synapse has enriched 10 related papers. Consider them for comparative context: